SLSN Quote, Financials, Valuation and Earnings

Flowerkist Skin Care & Cosmetics, Inc. has a net margin of -7.67% compared to Solesence, Inc.'s net margin of --. Solesence, Inc.'s return on equity of 6.62% beat Flowerkist Skin Care & Cosmetics, Inc.'s return on equity of --.

Solesence, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Flowerkist Skin Care & Cosmetics, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Solesence, Inc. has higher upside potential than Flowerkist Skin Care & Cosmetics, Inc., analysts believe Solesence, Inc. is more attractive than Flowerkist Skin Care & Cosmetics, Inc..

Solesence, Inc. has a beta of 1.092, which suggesting that the stock is 9.236% more volatile than S&P 500. In comparison Flowerkist Skin Care & Cosmetics, Inc. has a beta of -2.452, suggesting its less volatile than the S&P 500 by 345.205%.

Solesence, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Flowerkist Skin Care & Cosmetics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solesence, Inc. pays -- of its earnings as a dividend. Flowerkist Skin Care & Cosmetics, Inc. pays out -- of its earnings as a dividend.

Solesence, Inc. quarterly revenues are $14.6M, which are larger than Flowerkist Skin Care & Cosmetics, Inc. quarterly revenues of --. Solesence, Inc.'s net income of -$1.1M is higher than Flowerkist Skin Care & Cosmetics, Inc.'s net income of --. Notably, Solesence, Inc.'s price-to-earnings ratio is 95.00x while Flowerkist Skin Care & Cosmetics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solesence, Inc. is 1.53x versus -- for Flowerkist Skin Care & Cosmetics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health Co. has a net margin of -7.67% compared to Solesence, Inc.'s net margin of -15.61%. Solesence, Inc.'s return on equity of 6.62% beat The Beauty Health Co.'s return on equity of -19.76%.

Solesence, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand The Beauty Health Co. has an analysts' consensus of $1.96 which suggests that it could grow by 88.3%. Given that The Beauty Health Co. has higher upside potential than Solesence, Inc., analysts believe The Beauty Health Co. is more attractive than Solesence, Inc..

Solesence, Inc. has a beta of 1.092, which suggesting that the stock is 9.236% more volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.157, suggesting its more volatile than the S&P 500 by 15.687%.

Solesence, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solesence, Inc. pays -- of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.

Solesence, Inc. quarterly revenues are $14.6M, which are smaller than The Beauty Health Co. quarterly revenues of $70.7M. Solesence, Inc.'s net income of -$1.1M is higher than The Beauty Health Co.'s net income of -$11M. Notably, Solesence, Inc.'s price-to-earnings ratio is 95.00x while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solesence, Inc. is 1.53x versus 0.44x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

Sentient Brands Holdings, Inc. has a net margin of -7.67% compared to Solesence, Inc.'s net margin of -1.07%. Solesence, Inc.'s return on equity of 6.62% beat Sentient Brands Holdings, Inc.'s return on equity of --.

Solesence, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sentient Brands Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Solesence, Inc. has higher upside potential than Sentient Brands Holdings, Inc., analysts believe Solesence, Inc. is more attractive than Sentient Brands Holdings, Inc..

Solesence, Inc. has a beta of 1.092, which suggesting that the stock is 9.236% more volatile than S&P 500. In comparison Sentient Brands Holdings, Inc. has a beta of -0.096, suggesting its less volatile than the S&P 500 by 109.641%.

Solesence, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sentient Brands Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solesence, Inc. pays -- of its earnings as a dividend. Sentient Brands Holdings, Inc. pays out -- of its earnings as a dividend.

Solesence, Inc. quarterly revenues are $14.6M, which are larger than Sentient Brands Holdings, Inc. quarterly revenues of $373.8K. Solesence, Inc.'s net income of -$1.1M is lower than Sentient Brands Holdings, Inc.'s net income of -$4K. Notably, Solesence, Inc.'s price-to-earnings ratio is 95.00x while Sentient Brands Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solesence, Inc. is 1.53x versus 3.63x for Sentient Brands Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast Plc has a net margin of -7.67% compared to Solesence, Inc.'s net margin of --. Solesence, Inc.'s return on equity of 6.62% beat Waldencast Plc's return on equity of -5.64%.

Solesence, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Waldencast Plc has an analysts' consensus of $3.08 which suggests that it could grow by 70.83%. Given that Waldencast Plc has higher upside potential than Solesence, Inc., analysts believe Waldencast Plc is more attractive than Solesence, Inc..

Solesence, Inc. has a beta of 1.092, which suggesting that the stock is 9.236% more volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Solesence, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solesence, Inc. pays -- of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.

Solesence, Inc. quarterly revenues are $14.6M, which are larger than Waldencast Plc quarterly revenues of --. Solesence, Inc.'s net income of -$1.1M is higher than Waldencast Plc's net income of --. Notably, Solesence, Inc.'s price-to-earnings ratio is 95.00x while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solesence, Inc. is 1.53x versus 0.74x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.